FP prostanoid receptor-mediated induction of the expression of early growth response factor-1 by activation of a Ras/Raf/mitogen-activated protein kinase signaling cascade

Wei Xu, Chih Ling Chou, Haipeng Sun, Hiromichi Fujino, Qin Chen, John W Regan

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

FP prostanoid receptors are G-protein-coupled receptors whose physiological activator is prostaglandin-F (PGF). PGF has been implicated in wound healing and cardiac hypertrophy, which are both known to involve the induction of the immediate-early response gene, early growth response factor-1 (EGR-1). We hypothesized that activation of the human FP receptor by PGF could induce the expression of EGR-1 and found that 1 μMPGF produced a time-dependent induction of both mRNA and protein expression for EGR-1. This FP receptor-mediated induction of EGR-1 expression involved activation of the small GTPase Ras followed by activation of C-Raf and the mitogen-activated protein (MAP) kinase kinases 1 and 2 (MEK1/2). Thus, induction of EGR-1 expression by PGF was blocked using dominant-negative constructs of Ras and C-Raf and the Raf kinase inhibitor 4-(4-(3-(4-chloro-3-trifluoromethylphenyl)ureido)phenoxy)-pyridine-2- carboxyllic acid methyamide-4-methylbenzenesulfonate (BAY43-9006). Likewise, the MEK1/2 inhibitor 2′-amino-3′-methoxyflavone (PD98059) blocked the induction of EGR-1 expression by PGF. FP receptor stimulation by PGF induced the phosphorylation of C-Raf, MEK1/2, and extracellular signal-regulated kinases 1 and 2, consistent with the activation of a MAP kinase signaling cascade. PGF was also found to induce the expression of EGR-1 in rat cardiomyocytes through the activation of endogenous FP receptors. This induction of EGR-1 expression in cardiomyocytes also involved the activation of Raf and MAP kinase signaling and was dependent on the activation of protein kinase C. This is the first report to show the regulation of EGR-1 expression after PGF activation of FP receptors and suggests that this could be an early event involved in wound healing and cardiac hypertrophy.

Original languageEnglish (US)
Pages (from-to)111-118
Number of pages8
JournalMolecular Pharmacology
Volume73
Issue number1
DOIs
StatePublished - Jan 2008

Fingerprint

Dinoprost
Mitogen-Activated Protein Kinases
Intercellular Signaling Peptides and Proteins
MAP Kinase Kinase 2
MAP Kinase Kinase 1
raf Kinases
Cardiomegaly
Cardiac Myocytes
Wound Healing
prostaglandin F2alpha receptor
Immediate-Early Genes
Mitogen-Activated Protein Kinase 3
Monomeric GTP-Binding Proteins
Mitogen-Activated Protein Kinase 1
G-Protein-Coupled Receptors
Protein Kinase C
Phosphorylation
Messenger RNA

ASJC Scopus subject areas

  • Pharmacology

Cite this

FP prostanoid receptor-mediated induction of the expression of early growth response factor-1 by activation of a Ras/Raf/mitogen-activated protein kinase signaling cascade. / Xu, Wei; Chou, Chih Ling; Sun, Haipeng; Fujino, Hiromichi; Chen, Qin; Regan, John W.

In: Molecular Pharmacology, Vol. 73, No. 1, 01.2008, p. 111-118.

Research output: Contribution to journalArticle

@article{bffd0efeee0746c98e249f504b6a1de3,
title = "FP prostanoid receptor-mediated induction of the expression of early growth response factor-1 by activation of a Ras/Raf/mitogen-activated protein kinase signaling cascade",
abstract = "FP prostanoid receptors are G-protein-coupled receptors whose physiological activator is prostaglandin-F2α (PGF2α). PGF2α has been implicated in wound healing and cardiac hypertrophy, which are both known to involve the induction of the immediate-early response gene, early growth response factor-1 (EGR-1). We hypothesized that activation of the human FP receptor by PGF2α could induce the expression of EGR-1 and found that 1 μMPGF 2α produced a time-dependent induction of both mRNA and protein expression for EGR-1. This FP receptor-mediated induction of EGR-1 expression involved activation of the small GTPase Ras followed by activation of C-Raf and the mitogen-activated protein (MAP) kinase kinases 1 and 2 (MEK1/2). Thus, induction of EGR-1 expression by PGF2α was blocked using dominant-negative constructs of Ras and C-Raf and the Raf kinase inhibitor 4-(4-(3-(4-chloro-3-trifluoromethylphenyl)ureido)phenoxy)-pyridine-2- carboxyllic acid methyamide-4-methylbenzenesulfonate (BAY43-9006). Likewise, the MEK1/2 inhibitor 2′-amino-3′-methoxyflavone (PD98059) blocked the induction of EGR-1 expression by PGF2α. FP receptor stimulation by PGF2α induced the phosphorylation of C-Raf, MEK1/2, and extracellular signal-regulated kinases 1 and 2, consistent with the activation of a MAP kinase signaling cascade. PGF2α was also found to induce the expression of EGR-1 in rat cardiomyocytes through the activation of endogenous FP receptors. This induction of EGR-1 expression in cardiomyocytes also involved the activation of Raf and MAP kinase signaling and was dependent on the activation of protein kinase C. This is the first report to show the regulation of EGR-1 expression after PGF2α activation of FP receptors and suggests that this could be an early event involved in wound healing and cardiac hypertrophy.",
author = "Wei Xu and Chou, {Chih Ling} and Haipeng Sun and Hiromichi Fujino and Qin Chen and Regan, {John W}",
year = "2008",
month = "1",
doi = "10.1124/mol.107.038778",
language = "English (US)",
volume = "73",
pages = "111--118",
journal = "Molecular Pharmacology",
issn = "0026-895X",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "1",

}

TY - JOUR

T1 - FP prostanoid receptor-mediated induction of the expression of early growth response factor-1 by activation of a Ras/Raf/mitogen-activated protein kinase signaling cascade

AU - Xu, Wei

AU - Chou, Chih Ling

AU - Sun, Haipeng

AU - Fujino, Hiromichi

AU - Chen, Qin

AU - Regan, John W

PY - 2008/1

Y1 - 2008/1

N2 - FP prostanoid receptors are G-protein-coupled receptors whose physiological activator is prostaglandin-F2α (PGF2α). PGF2α has been implicated in wound healing and cardiac hypertrophy, which are both known to involve the induction of the immediate-early response gene, early growth response factor-1 (EGR-1). We hypothesized that activation of the human FP receptor by PGF2α could induce the expression of EGR-1 and found that 1 μMPGF 2α produced a time-dependent induction of both mRNA and protein expression for EGR-1. This FP receptor-mediated induction of EGR-1 expression involved activation of the small GTPase Ras followed by activation of C-Raf and the mitogen-activated protein (MAP) kinase kinases 1 and 2 (MEK1/2). Thus, induction of EGR-1 expression by PGF2α was blocked using dominant-negative constructs of Ras and C-Raf and the Raf kinase inhibitor 4-(4-(3-(4-chloro-3-trifluoromethylphenyl)ureido)phenoxy)-pyridine-2- carboxyllic acid methyamide-4-methylbenzenesulfonate (BAY43-9006). Likewise, the MEK1/2 inhibitor 2′-amino-3′-methoxyflavone (PD98059) blocked the induction of EGR-1 expression by PGF2α. FP receptor stimulation by PGF2α induced the phosphorylation of C-Raf, MEK1/2, and extracellular signal-regulated kinases 1 and 2, consistent with the activation of a MAP kinase signaling cascade. PGF2α was also found to induce the expression of EGR-1 in rat cardiomyocytes through the activation of endogenous FP receptors. This induction of EGR-1 expression in cardiomyocytes also involved the activation of Raf and MAP kinase signaling and was dependent on the activation of protein kinase C. This is the first report to show the regulation of EGR-1 expression after PGF2α activation of FP receptors and suggests that this could be an early event involved in wound healing and cardiac hypertrophy.

AB - FP prostanoid receptors are G-protein-coupled receptors whose physiological activator is prostaglandin-F2α (PGF2α). PGF2α has been implicated in wound healing and cardiac hypertrophy, which are both known to involve the induction of the immediate-early response gene, early growth response factor-1 (EGR-1). We hypothesized that activation of the human FP receptor by PGF2α could induce the expression of EGR-1 and found that 1 μMPGF 2α produced a time-dependent induction of both mRNA and protein expression for EGR-1. This FP receptor-mediated induction of EGR-1 expression involved activation of the small GTPase Ras followed by activation of C-Raf and the mitogen-activated protein (MAP) kinase kinases 1 and 2 (MEK1/2). Thus, induction of EGR-1 expression by PGF2α was blocked using dominant-negative constructs of Ras and C-Raf and the Raf kinase inhibitor 4-(4-(3-(4-chloro-3-trifluoromethylphenyl)ureido)phenoxy)-pyridine-2- carboxyllic acid methyamide-4-methylbenzenesulfonate (BAY43-9006). Likewise, the MEK1/2 inhibitor 2′-amino-3′-methoxyflavone (PD98059) blocked the induction of EGR-1 expression by PGF2α. FP receptor stimulation by PGF2α induced the phosphorylation of C-Raf, MEK1/2, and extracellular signal-regulated kinases 1 and 2, consistent with the activation of a MAP kinase signaling cascade. PGF2α was also found to induce the expression of EGR-1 in rat cardiomyocytes through the activation of endogenous FP receptors. This induction of EGR-1 expression in cardiomyocytes also involved the activation of Raf and MAP kinase signaling and was dependent on the activation of protein kinase C. This is the first report to show the regulation of EGR-1 expression after PGF2α activation of FP receptors and suggests that this could be an early event involved in wound healing and cardiac hypertrophy.

UR - http://www.scopus.com/inward/record.url?scp=37349052888&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=37349052888&partnerID=8YFLogxK

U2 - 10.1124/mol.107.038778

DO - 10.1124/mol.107.038778

M3 - Article

C2 - 17911534

AN - SCOPUS:37349052888

VL - 73

SP - 111

EP - 118

JO - Molecular Pharmacology

JF - Molecular Pharmacology

SN - 0026-895X

IS - 1

ER -